Sypharma partners with Vaxine Pty Ltd. to manufacture COVID-19 vaccine product
“This is the 16th vaccine to enter trials globally but is the first COVID-19 vaccine developed in the Southern hemisphere to enter human trials, and the first COVID-19 vaccine designed with the help of AI,” said Professor Nikolai Petrovsky.
Sypharma has a long-standing relationship with Vaxine with over a decade of manufacturing Advax delta inulin adjuvant, and are excited and are honored to partner with this groundbreaking work in bringing a CoVID-19 vaccine to market. Sypharma undertook the fill and finish of the CoVID-19 vaccine and the manufacture of the Advax delta inulin adjuvant products.
Link to the article
One thought on “Sypharma partners with Vaxine Pty Ltd. to manufacture COVID-19 vaccine product”
Richard Bentley
December 16, 2020 at 02:49 AMIt has been exciting to have a local candidate making progress through the evaluation processes.
I have difficulty understanding why it has not been followed more closely by the press. Particularly now the “favored” candidate has fallen over